These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 5347838

  • 1. Platelet transfusion therapy; the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing.
    Yankee RA, Grumet FC, Rogentine GN.
    N Engl J Med; 1969 Nov 27; 281(22):1208-12. PubMed ID: 5347838
    [No Abstract] [Full Text] [Related]

  • 2. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching.
    Yankee RA, Graff KS, Dowling R, Henderson ES.
    N Engl J Med; 1973 Apr 12; 288(15):760-4. PubMed ID: 4688715
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Importance of histocompatibility in platelet transfusion therapy.
    Yankee RA.
    Vox Sang; 1971 May 12; 20(5):419-26. PubMed ID: 4106552
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G, Appelbaum FR, Trapani RJ, Dowling R, Deisseroth AB.
    Transfusion; 1980 May 12; 20(1):47-54. PubMed ID: 7355471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HL-A matching in thrombocyte and leukocyte transfusions.
    Matej H, Olearczyk J, Partyka T, Kotlarek-Haus S, Stawarz M, Dzierzkowa-Borodej W.
    Arch Immunol Ther Exp (Warsz); 1975 May 12; 23(2):181-7. PubMed ID: 807177
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.
    Jeannet M, Rubinstein A, Pelet B, Kummer H.
    Transplant Proc; 1974 Dec 12; 6(4):359-63. PubMed ID: 4280163
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet transfusion therapy.
    Becker GA, Aster RH.
    Med Clin North Am; 1972 Jan 12; 56(1):81-94. PubMed ID: 4400082
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L, Woodfield DG.
    N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.